Journal for ImmunoTherapy of Cancer (Nov 2023)
274 Development of CTX112 a next generation allogeneic multiplexed CRISPR-edited CART cell therapy with disruptions of the TGFBR2 and Regnase-1 genes for improved manufacturing and potency
- Sarah Cohen,
- Jacob Waldman,
- Andrew Dunn,
- Thao Nguyen,
- Jonathan Terrett,
- Brigid Mcewan,
- Meghna Kuppuraju,
- Mohammed Ghonime,
- Robert Chain,
- Zinkal Padalia,
- Demetrios Kalaitzidis,
- Elizabeth Koch,
- Lauren Zakas,
- Nivedita Jaishankar,
- Davis Settipane,
- Paul Tetteh,
- Mary-Lee Dequeant,
- Sushant Karnik,
- Chandirasegaran Massilamany,
- Henia Dar,
- Melanie Allen,
- Laura Serwer,
- Melanie Butler-Gauthier,
- Parin Sripakdeevong,
- Shashwat Nagar,
- Yin Tang,
- Nicole Flanagan,
- Elaine Huang,
- Shashwant Phuyal,
- Erisa Sula,
- Maria Lei Zhang,
- Cristian Loaiza,
- Erin Thorstensen,
- Keith Steiger,
- Katie Schum,
- Kayla Urbaez,
- Anna Ma,
- Annie Yang Weaver,
- Christopher Finch,
- PK Morrow,
- Mark Benton
Affiliations
- Sarah Cohen
- CRISPR Therapeutics, Cambridge, MA, USA
- Jacob Waldman
- CRISPR Therapeutics, Cambridge, MA, USA
- Andrew Dunn
- CRISPR Therapeutics, Cambridge, MA, USA
- Thao Nguyen
- 1Lillehammer Hospital for Rheumatic Disease, Lillehammer, Norway
- Jonathan Terrett
- CRISPR Therapeutics, Cambridge, MA, USA
- Brigid Mcewan
- CRISPR Therapeutics, Cambridge, MA, USA
- Meghna Kuppuraju
- CRISPR Therapeutics, Cambridge, MA, USA
- Mohammed Ghonime
- CRISPR Therapeutics, Cambridge, MA, USA
- Robert Chain
- CRISPR Therapeutics, Cambridge, MA, USA
- Zinkal Padalia
- CRISPR Therapeutics, Cambridge, MA, USA
- Demetrios Kalaitzidis
- CRISPR Therapeutics, Cambridge, MA, USA
- Elizabeth Koch
- CRISPR Therapeutics, Cambridge, MA, USA
- Lauren Zakas
- CRISPR Therapeutics, Cambridge, MA, USA
- Nivedita Jaishankar
- CRISPR Therapeutics, Cambridge, MA, USA
- Davis Settipane
- CRISPR Therapeutics, Cambridge, MA, USA
- Paul Tetteh
- CRISPR Therapeutics, Cambridge, MA, USA
- Mary-Lee Dequeant
- CRISPR Therapeutics, Cambridge, MA, USA
- Sushant Karnik
- CRISPR Therapeutics, Cambridge, MA, USA
- Chandirasegaran Massilamany
- CRISPR Therapeutics, Cambridge, MA, USA
- Henia Dar
- CRISPR Therapeutics, Cambridge, MA, USA
- Melanie Allen
- CRISPR Therapeutics, Cambridge, MA, USA
- Laura Serwer
- CRISPR Therapeutics, Cambridge, MA, USA
- Melanie Butler-Gauthier
- CRISPR Therapeutics, Cambridge, MA, USA
- Parin Sripakdeevong
- CRISPR Therapeutics, Cambridge, MA, USA
- Shashwat Nagar
- CRISPR Therapeutics, Cambridge, MA, USA
- Yin Tang
- CRISPR Therapeutics, Cambridge, MA, USA
- Nicole Flanagan
- CRISPR Therapeutics, Cambridge, MA, USA
- Elaine Huang
- CRISPR Therapeutics, Cambridge, MA, USA
- Shashwant Phuyal
- CRISPR Therapeutics, Cambridge, MA, USA
- Erisa Sula
- CRISPR Therapeutics, Cambridge, MA, USA
- Maria Lei Zhang
- CRISPR Therapeutics, Cambridge, MA, USA
- Cristian Loaiza
- CRISPR Therapeutics, Cambridge, MA, USA
- Erin Thorstensen
- CRISPR Therapeutics, Cambridge, MA, USA
- Keith Steiger
- CRISPR Therapeutics, Cambridge, MA, USA
- Katie Schum
- CRISPR Therapeutics, Cambridge, MA, USA
- Kayla Urbaez
- CRISPR Therapeutics, Cambridge, MA, USA
- Anna Ma
- CRISPR Therapeutics, Cambridge, MA, USA
- Annie Yang Weaver
- CRISPR Therapeutics, Cambridge, MA, USA
- Christopher Finch
- CRISPR Therapeutics, Cambridge, MA, USA
- PK Morrow
- CRISPR Therapeutics, Cambridge, MA, USA
- Mark Benton
- CRISPR Therapeutics, Cambridge, MA, USA
- DOI
- https://doi.org/10.1136/jitc-2023-SITC2023.0274
- Journal volume & issue
-
Vol. 11,
no. Suppl 1
Abstract
No abstracts available.
